Skip to main content

Table 1 Socio-demographic characteristics

From: Does supportive supervision intervention improve community health worker knowledge and practices for community management of childhood diarrhea and pneumonia? Lessons for scale-up from Nigraan and Nigraan Plus trials in Pakistan

Characteristic

Nigraan (Badin)

Nigraan Plus (MPK)

LHSs (n = 34)

LHWs (n = 168)

LHSs (n = 32)

LHWs (n = 160)

Intervention (n = 17)

Control (n = 17)

Intervention (n = 84)

Control (n = 84)

Intervention (n = 16)

Control (n = 16)

Intervention (n = 80)

Control (n = 80)

Median age (min, max)*

37 (29, 45)

40 (32, 48) ‡

33 (22, 55)

36.5 (24, 59)

45 (40, 67)

43 (38, 57)

39 (25, 57)

41 (26, 59)

Education n (%)***

 Secondary

5 (29.4)

3 (17.6)

74 (89.2)

79 (94.0)

3 (20.0)

4 (28.6)

65 (92.9)

66 (90.4)

 Tertiary

12 (70.6)

14 (82.4)

9 (10.8)

5 (6.0)

12 (80)

14 (71.4)

5 (7.1)

7 (9.6)

Had previous experience before joining LHWP n (%)**

5 (29.4)

7 (41.2)

7 (8.3)

4 (4.8)

7 (58.3)

1 (12.5)

6 (11.3)

2 (6.7)

Median years of experience with LHWP (min, max)*

12 (0, 20)

14 (8, 20)

12 (0, 20)

13 (0, 21)

22 (14, 25)

20.5 (14, 24)

18 (1, 26)

17 (2, 25)

Marital status n (%)***

 Married

17 (100)

17 (100)

67 (79.8)

73 (86.9)

14 (93.3)

9 (81.8)

64 (88.9)

59 (90.8)

 Single

  

14 (16.7)

8 (9.5)

1 (6.7)

1 (9.1)

7 (9.7)

5 (7.7)

 Divorced

  

1 (1.2)

2 (2.4)

0 (0)

1 (9.1)

0 (0)

1 (1.5)

 Widowed

  

2 (2.4)

1 (1.2)

0 (0)

0 (0)

1 (1.4)

0 (0)

Lives in a household with < 5-year child n (%)***

9 (52.9)

6 (35.3)

39 (46.4)

45 (53.6)

2 (14.3)

5 (38.5)

26 (38.8)

30 (40.0)

Median time to reach health facility (min, max)*

15 (0,60)

20 (10, 60)

15 (0, 60)

20 (3, 60)

22 (14, 25)

20.5 (14, 24)

20 (5, 60)

25 (5, 120)

  1. LHWP Lady Health Worker Program, LHWs lady health workers, LHSs lady health supervisors
  2. Statistical tests applied for significance testing: *Mann–Whitney U-test. **Independent sample t-test. ***Pearson’s Chi-square
  3. Some missing values for LHWs in both trials and LHSs in MPK
  4. p-value > 0.05